Jamal Alzubi

697 total citations
20 papers, 452 citations indexed

About

Jamal Alzubi is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jamal Alzubi has authored 20 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Genetics. Recurrent topics in Jamal Alzubi's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (8 papers). Jamal Alzubi is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (8 papers) and CRISPR and Genetic Engineering (8 papers). Jamal Alzubi collaborates with scholars based in Germany, United Kingdom and United States. Jamal Alzubi's co-authors include Toni Cathomen, Claudio Mussolino, Thomas Lahaye, Thomas J. Cradick, Robert Morbitzer, Gang Bao, Eli J. Fine, Philipp Wolf, Christian Gratzke and Johannes Kuehle and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Jamal Alzubi

18 papers receiving 447 citations

Peers

Jamal Alzubi
Cornell Allen United States
Tyler E. Papp United States
Xiang Ao China
Samuele Ferrari Italy
Michael J. Torres United States
Michael Schmueck‐Henneresse Germany
Cindy R. Sandoval Espinoza United States
Andrea Brennan United States
Giandomenico Turchiano Italy
Nuphar Veiga Israel
Cornell Allen United States
Jamal Alzubi
Citations per year, relative to Jamal Alzubi Jamal Alzubi (= 1×) peers Cornell Allen

Countries citing papers authored by Jamal Alzubi

Since Specialization
Citations

This map shows the geographic impact of Jamal Alzubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Alzubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Alzubi more than expected).

Fields of papers citing papers by Jamal Alzubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamal Alzubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Alzubi. The network helps show where Jamal Alzubi may publish in the future.

Co-authorship network of co-authors of Jamal Alzubi

This figure shows the co-authorship network connecting the top 25 collaborators of Jamal Alzubi. A scholar is included among the top collaborators of Jamal Alzubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamal Alzubi. Jamal Alzubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Prateek, Jamal Alzubi, Andreas Vlachos, et al.. (2025). ID3-depleted human induced pluripotent stem cell–derived neural stem/progenitor cells promote neurorepair. Neural Regeneration Research.
2.
Monaco, Gianni, et al.. (2025). Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing. Molecular Therapy — Nucleic Acids. 36(3). 102618–102618. 2 indexed citations
3.
4.
Alzubi, Jamal, Manuel Rhiel, Valentina Pennucci, et al.. (2024). CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells. International Journal of Molecular Sciences. 25(2). 985–985. 3 indexed citations
5.
6.
Albinger, Nawid, Tobias Bexte, Jamal Alzubi, et al.. (2023). P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.. HemaSphere. 7(S3). e71265f8–e71265f8. 1 indexed citations
7.
Bexte, Tobias, Jamal Alzubi, Ralf Schubert, et al.. (2022). CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma. OncoImmunology. 11(1). 2081415–2081415. 52 indexed citations
8.
Albinger, Nawid, Tobias Bexte, Jamal Alzubi, et al.. (2022). CRISPR/Cas9 Gene Editing of Immune Checkpoint Receptor NKG2A Improves the Efficacy of Primary CD33-CAR-NK Cells Against AML. Blood. 140(Supplement 1). 4558–4559. 16 indexed citations
9.
Wolf, Philipp, Jamal Alzubi, Christian Gratzke, & Toni Cathomen. (2021). The potential of CAR T cell therapy for prostate cancer. Nature Reviews Urology. 18(9). 556–571. 38 indexed citations
10.
Arbuthnot, Patrick, et al.. (2021). Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells. Gene Therapy. 28(9). 602–612. 10 indexed citations
11.
Alzubi, Jamal, Johannes Kuehle, Maximilian Seidl, et al.. (2020). PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Molecular Therapy — Oncolytics. 18. 226–235. 41 indexed citations
12.
Elling, Roland, Jamal Alzubi, Julia Kolter, et al.. (2020). Modeling MyD88 Deficiency In Vitro Provides New Insights in Its Function. Frontiers in Immunology. 11. 608802–608802. 8 indexed citations
13.
Alzubi, Jamal, Dominik Lock, Manuel Rhiel, et al.. (2020). Automated generation of gene-edited CAR T cells at clinical scale. Molecular Therapy — Methods & Clinical Development. 20. 379–388. 41 indexed citations
14.
Tarakanchikova, Yana V., Jamal Alzubi, Valentina Pennucci, et al.. (2019). Biodegradable Nanocarriers Resembling Extracellular Vesicles Deliver Genetic Material with the Highest Efficiency to Various Cell Types. Small. 16(3). e1904880–e1904880. 31 indexed citations
15.
Mussolino, Claudio, Jamal Alzubi, Valentina Pennucci, Giandomenico Turchiano, & Toni Cathomen. (2017). Genome and Epigenome Editing to Treat Disorders of the Hematopoietic System. Human Gene Therapy. 28(11). 1105–1115. 15 indexed citations
16.
Alzubi, Jamal, Celeste Pallant, Claudio Mussolino, et al.. (2017). Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model. Scientific Reports. 7(1). 12475–12475. 6 indexed citations
17.
Kuehle, Johannes, Christian Reimann, Jamal Alzubi, et al.. (2015). Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. PLoS Genetics. 11(5). e1005239–e1005239. 9 indexed citations
18.
Bobis‐Wozowicz, Sylwia, Melanie Galla, Jamal Alzubi, et al.. (2014). Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery. Scientific Reports. 4(1). 4656–4656. 23 indexed citations
19.
Mussolino, Claudio, Jamal Alzubi, Eli J. Fine, et al.. (2014). TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Research. 42(10). 6762–6773. 131 indexed citations
20.
Alzubi, Jamal, et al.. (2013). TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting. PLoS ONE. 8(12). e82539–e82539. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornell Allen Breakdown of academic impact, for papers by Tyler E. Papp Breakdown of academic impact, for papers by Xiang Ao Breakdown of academic impact, for papers by Samuele Ferrari Breakdown of academic impact, for papers by Michael J. Torres Breakdown of academic impact, for papers by Michael Schmueck‐Henneresse Breakdown of academic impact, for papers by Cindy R. Sandoval Espinoza Breakdown of academic impact, for papers by Andrea Brennan Breakdown of academic impact, for papers by Giandomenico Turchiano Breakdown of academic impact, for papers by Nuphar Veiga
Rankless by CCL
2026